You just read:

Neurocrine Biosciences Will File New Drug Application for Opicapone for Parkinson's Disease Based on Existing Pivotal Clinical Trial Data

News provided by

Neurocrine Biosciences, Inc.

Feb 14, 2018, 16:01 ET